Prandial glucose regulation and cardiovascular disease in Type 2 diabetes

European Journal of Clinical Investigation, Supplement

Volumn 29, Issue 2, 1999, Pages 7-11

  Kuusisto, J ^a   Laakso, M ^a  

^a UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Cardiovascular disease; Glucose; Hyperglycaemia; Type 2 diabetes

Indexed keywords

ANTIDIABETIC AGENT; GLUCOSE;

CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CONFERENCE PAPER; GLUCOSE BLOOD LEVEL; HUMAN; HYPERGLYCEMIA; MORBIDITY; MORTALITY; NON INSULIN DEPENDENT DIABETES MELLITUS; POSTPRANDIAL STATE; PRIORITY JOURNAL; RISK FACTOR;

EID: 28144449495     PISSN: 0960135X     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2362.1999.00006.x     Document Type: Conference Paper

References (42)

1. Laakso M, Reunanen A, Klaukka T, Aromaa A, Maatela J, Pyörälä K. Changes in the prevalence and incidence of diabetes mellitus in Finnish adults, 1970-1987. Am J Epidemiol 1991; 133: 850-7.
2. Wingard DL, Sinsheimer P, Barrett-Connor EL, McPhillips JB. Community-based study of prevalence of NIDDM in older adults. Diabetes Care 1990; 13 (Suppl. 2): 3-8.
3. Harris MI, Madden WC, Knowler WC, Bennett PH. Prevalence of diabetes and impaired glucose tolerance and plasma glucose levels in US population aged 20-74 years. Diabetes 1987; 36: 523-34.
4. Andersson DKG, Svärdsudd K, Tibblin G. Prevalence and incidence of diabetes in a Swedish community 1972-1987. Diabetic Medicine 1991; 8: 428-34.
5. Davidson MB, The effect of aging on carbohydrate metabolism: A review on the English literature and a practical approach to the diagnosis of diabetes mellitus in the elderly. Metabolism 1979; 28: 688-705.
6. Pan WH, Cedres LB, Liu K, Dyer A, Schoenberger JA, Shekelle RB, Stamler R, Smith D, Collette P, Stamler J. Relationship of clinical diabetes and asymptomatic hyperglycemia to risk of coronary heart disease mortality in men and women. Am J Epidemiol 1986; 123: 504-16.
7. Fuller JH, Shipley MJ, Rose G, Jarrett RJ, Keen H. Mortality from coronary heart disease and stroke in relation to glycemia: The Whitehall Study. Br Med J 1983; 287: 867-70.
8. Eschwege E, Richard JL, Thibult N, Ducimetiere P, Warnet JM, Claude JR, Rosselin GE. Coronary heart disease mortality in relation with diabetes, blood glucose and plasma insulin levels. The Paris Prospective Study, ten years later. Horm Metab Res 1985; 15 (Suppl.): 41-6.
9. Mykkänen L, Laakso M, Uusitupa M, Pyörälä K. Prevalence of diabetes and impaired glucose tolerance in elderly subjects and their association with obesity and family history of diabetes. Diabetes Care 1990; 13: 1099-105.
10. WHO Expert Committee on Diabetes Mellitus. Second report: World Health Organization technical report series 646. Geneva: World Health Organization, 1980.
11. Pyörälä K, Laakso M, Uusitupa M. Diabetes and atherosclerosis: an epidemiologic view. Diabetes Metab Rev 1987; 3: 463-524.
12. Laakso M, Lehto S. Epidemiology of macrovascular disease in diabetes. Diabetes Rev 1997; 5: 294-315.
13. West KM, Ahuja MMS, Bennet PH, Czyzyk A, De-Acosta OM, Fuller JH, Grab B, Grabauskas V, Jarrett RJ, Kosaka K. The role of circulating glucose and triglyceride concentrations and their interactions with other 'risk factors' as determinants of arterial disease in nine diabetic population samples from the WHO multinational study. Diabetes Care 1983; 6: 361-9.
14. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. Non-insulin-dependent diabetes and its metabolic control are important predictors of stroke in elderly subjects. Stroke 1994; 25: 1157-64.
15. Siitonen OI, Niskanen LK, Laakso M, Siitonen JT, Pyörälä K. Lower-extremity amputations in diabetic and nondiabetic patients. Diabetes Care 1993; 16: 16-20.
16. Haffner SM, Stern MP, Hazuda HP, Mitschell BD, Patterson JK. Cardiovascular risk factors in confirmed prediabetic individuals. Does the clock for coronary heart disease start ticking before the onset of clinical diabetes? J Am Med Assoc 1990; 263: 2893-8.
17. International Collaborative Group. Asymptomatic hyperglycemia and coronary heart disease: a series of papers by the International Collaborative Group based on studies in fifteen populations. J Chronic Dis 1979; 32: 829-37.
18. Balkau B, Shipley M, Jarrett RJ, Pyörälä K, Pyörälä M, Forhan A, Eschwege E. High blood glucose concentration is a risk factor for mortality in middle-aged nondiabetic men. Diabetes Care 1998; 21: 360-6.
19. Wilson PWF, Cupples LA, Kannel WB. Is hyperglycemia associated with cardiovascular disease? The Framingham Study. Am Heart J 1991; 121: 586-90.
20. Scheidt-Navc C, Barrett-Connor E, Wingard DL, Cohn BA, Edelstein SL. Sex differences in fasting glycemia as a risk factor for ischemic heart death. Am J Epidemiol 1991; 133: 565-76.
21. Donahue RP, Abbott RD, Reed DM, Yano K. Postchallenge glucose concentration and coronary heart disease in men of Japanese anchestry. Honolulu Heart Program. Diabetes 1987; 36: 689-92.
22. Perry IJ, Wannamethee SG, Whincup PH, Shaper AG. Asymptomatic hyperglycaemia and major ischaemic health disease events in Britain. J Epidemiol Community Health 1994; 48: 538-43.
23. Coutinho M, Wang Y, Gerstein HC, Yusuf S. Continuous relationship of glucose with cardiovascular events in nondiabetic subjects: a meta regression analysis of 18 studies in 88 000 individuals (Abstract). Circulation 1996; 94 (Suppl. 8): 1-214.
24. Ishihara M, Yukimura Y, Yamada T, Ohto K, Yoshizawa K. Diabetic complications and their relationship to risk factors in a Japanese population. Diabetes Care 1984; 7: 533-8.
25. Welborn TA, Knuiman M, McCann V, Stanton K, Constable IJ. Clinical macrovascular disease in Caucasoid diabetic subjects: logistic regression analysis of risk variables. Diabetologia 1984; 27: 568-73.
26. 1c with prevalent cardiovascular disease in the original cohort of the Framingham Heart Study. Diabetes 1992; 41: 202-8.
27. Uusitupa MIJ, Niskanen LK, Voutilainen E, Pyörälä K. Ten-year cardiovascular mortality in relation to risk factors and abnormalities in lipoprotein composition in type 2 (non-insulin-dependent) diabetic and non-diabetic subjects. Diabetologia 1993; 36: 1175-84.
28. Andersson DKG, Svärdsudd K. Long-term glycemic control relates to mortality in type II diabetes. Diabetes Care 1995; 18: 1534-43.
29. Hanefeld M, Fischer S, Julius U, Schulze J, Schwancbeck U, Schmechel H, Ziegelasch HJ, Lindner J, The DIS Group. Risk factors for myocardial infarction and death in newly detected NIDDM: the Diabetes Intervention Study: 11-year follow-up. Diabetologia 1996; 39: 1577-83.
30. Kuusisto J, Mykkänen L, Pyörälä K, Laakso M. NIDDM and its metabolic control predict coronary heart disease in elderly subjects. Diabetes 1994; 43: 960-7.
31. Klein R. Hyperglycemia and microvascular and macrovascular disease in diabetes. Diabetes Care 1995; 18: 258-68.
32. Gall M-A, Borch-Johnsen K, Hougaard P, Nielsen FS, Parving HH. Albuminuria and poor glycemic control predict mortality in NIDDM. Diabetes, 1995; 44: 1303-9.
33. Standl E, Balletshofer B, Dahl B, Weichenhain B, Stiegler H, Hörmann A, Holle R. Predictors of 10-year macrovascular and overall mortality in patients with NIDDM: the Munich General Parctioner Project. Diabetologia 1996; 39: 1540-5.
34. Lehto S, Rönnemaa T, Haffner SM, Pyörälä K, Kallio V, Laakso M. Dyslipidemia and hyperglycemia predict coronary heart disease events in middle-aged patients with NIDDM. Diabetes 1997; 48: 1354-9.
35. Lehto S, Rönnemaa T, Pyörälä K, Laakso M. Predictors of stroke in middle-aged patients with non-insulin dependent diabetes. Stroke 1996; 27: 63-8.
36. Turner RC, Millns H, Neil HAW, Strattom IM, Manley SE, Matthews DR, Holman RR for the United Kingdom Prospective Diabetes Study Group. Risk factors for coronary artery disease in non-insulin dependent diabetes mellitus: United Kingdom Prospective Diabetes Study (UKPDS: 23). Br Med J 1998; 316: 823-8.
37. Landerson JH, Chan KM, Kilzen P, Glycated hemoglobin and diabetes: a case and overview of the subject. Clin Chem 1985; 31: 1060-7.
38. Bierman EL. Atherogenesis in diabetes. Arterioscler Thromb 1992; 12: 647-56.
39. Makita Z, Radoff S, Rayfield EJ, Yang Z, Skolnik E, Delaney V, Friedman EA, Cerami A, Vlassara H. Advanced glycosylation end products in patients with diabetic nephropathy. N Engl J Med 1991; 8: 36-42.
40. Libby P. Molecular bases of the acute coronary syndromes. Circulation 1995; 91: 2844-50.
41. Badimon JJ, Fuster V, Chesebro JH, Badimon L. Coronary atherosclerosis - a multifactorial disease. Circulation 1993; 87 (Suppl. II): 3-16.
42. UK Prospective Diabetes Study Group. UK. Prospective Diabetes Study 16. Overview of 6 years' therapy of type II diabetes: A progressive disease. Diabetes 1995; 44: 1249-58.